Fig. 4.
Differences in methylation status of MGMT and p16 in tumors of patients with a family history of colorectal cancer and in those with sporadic colorectal cancer. Compared with sporadic colorectal cancers, MGMT was more frequently (p=0.016) and p16 was less frequently (p=0.046) methylated in colorectal cancers from patients with a family history.
